Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|January 30, 2025
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor ModelsGuillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.Chemmedchem|April 6, 2024
Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding FragmentsStuart Lang, Daniel A Fletcher, Alain-Pierre Petit, et al.Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenaseJason D Oliver, Graham E M Sibley, Nicola Beckmann, et al.The Journal of Organic Chemistry|March 25, 2008
Asymmetric synthesis of an N-acylpyrrolidine for inhibition of HCV polymeraseArmel A Agbodjan, Bob E Cooley, Royston C B Copley, et al.Journal of Medicinal Chemistry|February 3, 2007
Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidateMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.Journal of Medicinal Chemistry|July 25, 2017
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related BiomarkersNahoum G Anthony, Jessica Baiget, Giacomo Berretta, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronatesXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.Pageof 3